 SEATTLE, Jan. 24, 2022 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Nasdaq: ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Tuesday, February 15, 2022. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 